These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32008042)

  • 1. Domain-specific introduction to machine learning terminology, pitfalls and opportunities in CRISPR-based gene editing.
    O'Brien AR; Burgio G; Bauer DC
    Brief Bioinform; 2021 Jan; 22(1):308-314. PubMed ID: 32008042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methods of Evaluating the Efficiency of CRISPR/Cas Genome Editing].
    Lomov NA; Viushkov VS; Petrenko AP; Syrkina MS; Rubtsov MA
    Mol Biol (Mosk); 2019; 53(6):982-997. PubMed ID: 31876277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting CRISPR/Cas9-Induced Mutations for Precise Genome Editing.
    Molla KA; Yang Y
    Trends Biotechnol; 2020 Feb; 38(2):136-141. PubMed ID: 31526571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PreAcrs: a machine learning framework for identifying anti-CRISPR proteins.
    Zhu L; Wang X; Li F; Song J
    BMC Bioinformatics; 2022 Oct; 23(1):444. PubMed ID: 36284264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VARSCOT: variant-aware detection and scoring enables sensitive and personalized off-target detection for CRISPR-Cas9.
    Wilson LOW; Hetzel S; Pockrandt C; Reinert K; Bauer DC
    BMC Biotechnol; 2019 Jun; 19(1):40. PubMed ID: 31248401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current advances in overcoming obstacles of CRISPR/Cas9 off-target genome editing.
    Aquino-Jarquin G
    Mol Genet Metab; 2021; 134(1-2):77-86. PubMed ID: 34391646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using traditional machine learning and deep learning methods for on- and off-target prediction in CRISPR/Cas9: a review.
    Sherkatghanad Z; Abdar M; Charlier J; Makarenkov V
    Brief Bioinform; 2023 May; 24(3):. PubMed ID: 37080758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for the CRISPR-Based Therapeutics.
    Li B; Niu Y; Ji W; Dong Y
    Trends Pharmacol Sci; 2020 Jan; 41(1):55-65. PubMed ID: 31862124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Various Aspects of a Gene Editing System-CRISPR-Cas9.
    Janik E; Niemcewicz M; Ceremuga M; Krzowski L; Saluk-Bijak J; Bijak M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of machine learning in the CRISPR/Cas9 system].
    Zhang GS; Yang Y; Zhang LM; Dai XH
    Yi Chuan; 2018 Sep; 40(9):704-723. PubMed ID: 30369475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Tools and Resources for CRISPR/Cas Genome Editing.
    Li C; Chu W; Gill RA; Sang S; Shi Y; Hu X; Yang Y; Zaman QU; Zhang B
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):108-126. PubMed ID: 35341983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR FokI Dead Cas9 System: Principles and Applications in Genome Engineering.
    Saifaldeen M; Al-Ansari DE; Ramotar D; Aouida M
    Cells; 2020 Nov; 9(11):. PubMed ID: 33233344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BoostMEC: predicting CRISPR-Cas9 cleavage efficiency through boosting models.
    Zarate OA; Yang Y; Wang X; Wang JP
    BMC Bioinformatics; 2022 Oct; 23(1):446. PubMed ID: 36289480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology.
    Zhang D; Li Z; Li JF
    J Genet Genomics; 2016 May; 43(5):251-62. PubMed ID: 27165865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.
    Tarasava K; Oh EJ; Eckert CA; Gill RT
    Biotechnol J; 2018 Sep; 13(9):e1700586. PubMed ID: 29917318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production.
    Zhang J; Zong W; Hong W; Zhang ZT; Wang Y
    Metab Eng; 2018 May; 47():49-59. PubMed ID: 29530750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 Editing of the Plasmodium falciparum Genome.
    Adjalley S; Lee MCS
    Methods Mol Biol; 2022; 2470():221-239. PubMed ID: 35881349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Bioinformatics Tools to Optimize CRISPR/Cas9 Experiments to Reduce Off-Target Effects.
    Naeem M; Alkhnbashi OS
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
    Ishino Y; Krupovic M; Forterre P
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.